Lite Strategy, Inc.
LITS
Rank in Stocks
#25051
Lite Strategy, Inc. functions as a clinical-stage pharmaceutical firm,... Lite Strategy, Inc. functions as a clinical-stage pharmaceutical firm, concentrating its efforts on creating innovative and distinct therapeutic solutions for cancer patients. This entity, which was previously known as MEI Pharma, Inc., officially changed its designation to Lite Strategy, Inc. in September 2025. The company was established in 2000 and has its principal operations located in San Diego, California.
Share Price
$0.8026
Last synced: 2026-11-20
Market Cap
$26.62M
Change (1 day)
-4.03%
Change (1 year)
-52.79%
Country
Stock data: Financial Modeling PrepยทUpdated ยทNot investment adviceยทHow we calculate this
Trade Lite Strategy, Inc. (LITS)
Category
Healthcare
Dividend history for Lite Strategy, Inc. (LITS)
Lite Strategy, Inc. (stock symbol: LITS) made a total of 1 dividend payments.
The sum of all dividends (adjusted for stock splits) is : $1.75
Dividend yield (TTM) : 0.00%
The sum of all dividends (adjusted for stock splits) is : $1.75
Dividend yield (TTM) : 0.00%
Dividend payments for Lite Strategy, Inc. (LITS) from 2023 to 2026
Annual dividend payments
| Year | Dividend (stock split adjusted) | Change |
|---|---|---|
| 2026 (TTM) | $1.75 | 0.00% |
| 2023 | $1.75 | 0.00% |
List of all dividend payments
| Year | Dividend | Change |
|---|---|---|
| 2026 (TTM) | $1.75 | 0.00% |
| 2023 | $1.75 | 0.00% |
Dividend payments for similar companies or competitors
| Company | Number of dividend payments | Country |
|---|---|---|
| 0.00% |
US
|
|
| 0.00% |
US
|
|
| 69.00% |
AU
|
|
| 0.00% |
NL
|
|
| 30.00% |
BE
|